New

From idea to ETF portfolio in minutes. Build yours now →

Advertisement
Advertisement

JDOCvsIXJETF Comparison

ETF 1
JDOC

JPMorgan Healthcare Leaders ETF

This fund is part of
Global Blended Cap
-0.17%
VS
ETF 2
IXJ

iShares Global Healthcare ETF

This fund is part of
Global Large Cap
-0.36%

JPMorgan Healthcare Leaders ETF (JDOC) belongs to the Global Blended Cap segment. iShares Global Healthcare ETF (IXJ) is part of the Global Large Cap segment. JDOC's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, IXJ's top sector exposures are Healthcare, Consumer Non-Cyclicals and Consumer Cyclicals. JDOC is more expensive with a Total Expense Ratio (TER) of 0.65%, versus 0.38% for IXJ. JDOC is up 12.75% year-to-date (YTD) with -$34K in YTD flows. IXJ performs better with 15.88% YTD performance, and -$490M in YTD flows. Run a side-by-side ETF comparison of JDOC and IXJ below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

JDOC vs IXJ performance and flow charts

Performance

-2.00.02.04.06.08.0%Sep 29Oct 6Oct 13Oct 20Oct 27

Cumulative Flows

-100 M-80 M-60 M-40 M-20 M0 MSep 29Oct 6Oct 13Oct 20Oct 27

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/29/2026
1M3MYTD1Y3Y5Y
Perf.
JDOC
IXJ
+6.85%+7.92%
+5.42%+9.21%
+12.75%+15.88%
+20.28%+24.62%
+36.30%+48.00%
n/a+37.20%
Flows
JDOC
IXJ
--$103M
-+$66M
-$34K-$490M
-$34K-$351M
+$7M-$619M
-+$13M
Volatility and drawdown
3M1Y3Y5Y
Volatility
JDOC
IXJ
+16.15%+17.10%
+15.63%+15.93%
+14.86%+14.42%
n/a+14.66%
Max drawdown
JDOC
IXJ
-7.92%-6.30%
-9.66%-10.83%
-24.04%-18.04%
n/a-18.04%
Max drawdown duration
JDOC
IXJ
64d55d
154d122d
704d490d
n/a490d
Trading data

Create an account to view trading data

Join for free
JDOC
IXJ
Last sale
10/30/2026 at 1:30 PM
$65.66
$112.66
Previous close
10/29/2026
$65.34
$111.74
Consolidated volume
10/29/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

JDOC
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
JDOC
IXJ
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 10/30/2026 at 1:30 PM
Live
Closed
JDOC
IXJ
Last price
$65.66
$112.66
1D performance
+0.49%
+0.82%
AuM$9.78 M$4.62 B
E/R0.65%0.38%
Characteristics
JDOC
IXJ
Management strategyActivePassive
ProviderJ.P. Morgan Asset ManagementiShares
Benchmark-S&P Global 1200 Health Care (Sector) Capped Index
N° of holdings57109
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateNovember 1, 2023November 13, 2001
ESGNoNo
Advertisement
Exposure

Countries

JDOC
USA
73.09%
Other
26.91%
IXJ
USA
71.85%
Switzerland
9.64%
Other
18.51%

Sectors

JDOC
Healthcare
96.41%
Other
3.59%
IXJ
Healthcare
97.24%
Other
2.76%

Diversification

JDOC

Total weight of top 15 holdings out of 15

60.13%
IXJ

Total weight of top 15 holdings out of 15

57.19%

Top 15 holdings

Data as of September 30, 2026
JDOC
AbbVie, Inc.
8.30%
Eli Lilly & Co.
7.97%
Merck & Co., Inc.
5.08%
Johnson & Johnson
4.98%
Thermo Fisher Scientific, Inc.
4.61%
AstraZeneca PLC
4.10%
UnitedHealth Group, Inc.
3.60%
Bristol Myers Squibb Co.
3.18%
Abbott Laboratories
2.97%
Roche Holding AG
2.81%
Danaher Corp.
2.76%
argenx SE
2.65%
Novo Nordisk A/S
2.57%
IQVIA Holdings, Inc.
2.31%
CVS Health Corp.
2.23%
IXJ
Eli Lilly & Co.
10.43%
Johnson & Johnson
7.19%
AbbVie, Inc.
5.21%
Merck & Co., Inc.
4.43%
UnitedHealth Group, Inc.
4.07%
Roche Holding AG
3.64%
Novartis AG
3.26%
AstraZeneca PLC
3.13%
Thermo Fisher Scientific, Inc.
3.09%
Amgen, Inc.
2.82%
Gilead Sciences, Inc.
2.29%
Abbott Laboratories
2.12%
Pfizer Inc.
2.01%
Intuitive Surgical, Inc.
1.78%
Danaher Corp.
1.72%
Frequently asked questions about JDOC and IXJ

How have the JDOC and IXJ ETFs performed in 2026?

As of October 29, 2026, JDOC is up 12.75% year-to-date (YTD), while IXJ has returned 15.88%. That puts IXJ better performer ahead so far this year.

Which ETF is attracting more investor money: JDOC or IXJ?

Year-to-date, the JDOC ETF saw -$34K in flows, compared to -$490M for IXJ.

Which ETF is more volatile: JDOC or IXJ?

Over the past year, JDOC had a volatility of 15.63%, while IXJ experienced 15.93%.

Which ETF is bigger: JDOC or IXJ?

As of October 29, 2026, JDOC holds $9.78 M in assets under management (AUM), while IXJ manages $4.62 B.

What sectors do the JDOC and IXJ ETFs invest in?

JDOC leans toward sectors like Healthcare. Meanwhile, IXJ focuses on Healthcare.

What are the top holdings of the JDOC ETF and IXJ ETF?

JDOC top holdings include AbbVie, Inc., Eli Lilly & Co. and Merck & Co., Inc.. IXJ holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: JDOC or IXJ?

JDOC holds 58 securities with 60.13% of its assets in the top 15. IXJ has 110 securities and a top 15 weight of 57.19%.

Advertisement
Latest news about JDOC & IXJ
Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026